BioTech Breakthrough’s Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industry “We believe EsoGuard, the first and only commercially available diagnostic ...

Castle Biosciences’ TissueCypher® test can offer patients with Barrett’s esophagus a clearer picture of their risk of developing esophageal cancer. Esophageal cancer is a killer. It’s the eighth most ...

FULLERTON, Calif. (KABC) -- The latest findings reveal esophageal cancer rates are up across the board. Many factors can raise your risk, including your line of work. A recently FDA-approved, ...

ProPhase Labs announces BE-Smart's validation for esophageal disease diagnostics, achieving over 95% success in detecting critical biomarkers. ProPhase Labs Inc. announced the successful validation of ...

Garden City, NY, April 10, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today reported its progress ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from a patient ...

Exact Sciences has put forward positive data on its approach to screening for esophageal tumors and the disease’s precancerous conditions with a method that may allow patients to skip a sedated ...

Investigators at the Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test ...

Doctors may perform endoscopies to diagnose esophageal cancer. They may also order laboratory tests and other imaging tests, such as MRI and CT scans, to confirm the diagnosis and determine whether ...

NEW YORK--(BUSINESS WIRE)--Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of ...